Lecture 3 - Introduction to Pharmaceutical Care Flashcards

1
Q

How has the pharmacy practice evolved?

A

Pharmacy has evolved from being a product focused profession towards a patient-centred profession. It’s not just about the drug, but also about managing patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The new pharmaceutical act has expanded the role of pharmacists. Explain

A

Pharmacists can now order lab tests in a community setting, they can give vaccinations and injections, they can order prescriptions, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the benefits of pharmacist-managed medication services?

A

Increased patient safety (less side effects), improved disease state management/improved efficacy, more effective health care spending (shorter hospital stays, less patients being admitted), improved adherence, improved quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What can patient-centred care mean for the patients?/How does patient-centred care impact patients?

A
  • Health/medication counseling and education
  • Medication review
  • Clinical services (therapeutic drug monitoring, clinical monitoring for effectiveness and/or side effects/toxicity)
  • Screening for diseases
  • Developing and implementing pharmacotherapeutic care plans
  • Recommending or prescribing medications
  • Referral to other health care professionals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why has the need for patient-centre pharmaceutical care emerged?

A
  • Multiple prescribers of medications
  • Large numebr of differing medications in patient’s regimen
  • Emergence in patient autonomy: the right of patients to guide decisions about their own medical care
  • Increased complexity of pharmacotherapy
  • Increased self-care (OTC, natural medicines, etc.)
  • Significant level of drug-induced morbidity and mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the definition of pharmaceutical care?

A

Patient-centred practice in which the practitioner assumes responsibility for a patient’s drug-related needs and is held accountable for this commitment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the goal of pharmaceutical care?

A

Optimization of all the patient’s drug therapy to achieve the best possible patient outcome and improve that patient’s quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the method used in pharmaceutical care? Explain

A

The Pharmacotherapy Workup. It’s a thought process for pharmacotherapeutic clinical decision-making. It’s important for (1) efficiently solving common problems as well as (2) provides a framework for novel scenarios

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The assessment is a crucial component of the pharmaceutical care process. Explain

A
  • Meeting the patient and obtaining consent
  • Eliciting relevant information (past medical history, history of presenting illness, current medications, allergies, pregnancy/nursing considerations, culture and/or patient-specific issues)
  • The Pharmacotherapy Workup
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are questions asked during the Pharmacotherapy Workup

A

Is the problem being caused by a drug? Can the problem be treated using drug therapy?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the goal of the assessment?

A

To evaluate if that patient’s drug-related needs are being met

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens if the drug-related needs of a patient are not being met?

A

That patient can be identified as having a drug-related problem (DRP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the seven DRPs

A
  1. Drug therapy is needed
  2. Drug therapy is not indicated for a specific drug the patient is currently taking
  3. Drug therapy is ineffective/more effective drug available
  4. Dose is too low
  5. Dose is too high
  6. Drug is causing an adverse effect (side-effect; drug-interaction; pregnancy or nursing considerations)
  7. Patient is not adhering to the prescribed regimen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What follows the assessment?

A
You may gain more information (symptoms worsening, describing specific signs, timeline, daily life, etc.)
Determine is drug therapy is needed
Determine a pharmacotherapeutic plan
-Evaluate appropriateness
-Evaluate effectiveness
-Evaluate safety
-Evaluate adherence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does a pharmacist evaluate appropriateness?

A

Evaluating appropriateness: in other words, looking at current guideline recommendations, which agents are recommended as potential options in a patient with presenting illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does a pharmacist evaluate effectiveness?

A

Do a significantly larger number of patients predictably respond to therapy with one agent over the other? Is there a greater intensity of response with one agent over the other? Is there a longer duration of response with one agent over the other? Is there a greater body of research and study with one agent over the other?

17
Q

How does a pharmacist evaluate safety?

A

Evaluate safety: in other words, does one agent have significant advantage in terms of less side-effects, drug interactions with concurrent medications, safety in pregnancy, etc.

18
Q

How does a pharmacist evaluate adherence?

A

Dose frequency: once or twice daily vs over 3 times daily
Dose form: is one agent available as an oral tablet vs an injection; messy ointment vs. fully absorbed cream; bitter-tasting suspension vs. palatable chewtab etc.
Cost
Coverage by provincial/federal and/or third-party payors

19
Q

What is the importance of developing a monitoring plan?

A

Developing a monitoring plan and ensuring patient follow-up is just as important as the drug selection process. What can the patient expect for improvement (either as clinical symptoms or laboratory monitoring) and when? (ex. 50% reduction of pain, 1-2 weeks after starting therapy; resolution of fever within 24-48 hours of starting antibiotics

20
Q

How does a pharmacist monitor safety of a regimen?

A

Warn patients about common side-effects
Provide advice for prevention and relief of side-effects
Provide advice for preventing drug-drug & drug-food interactions (ex. grapefruit juice)
Provide guidance on which side effects are common and self-manageable vs. those that need immediate follow-up with the pharmacist or MD (watch and wait vs. see pharmacist or MD in a timely manner vs. seek urgent attention at emergency department)